Application of high-strength biodegradable polyurethanes containing different ratios of biobased isomannide and poly (ϵ-caprolactone) diol
Source abstract
Abstract
Biodegradable–biocompatible polyurethanes were prepared with fixed hexamethylene diisocyanate and varying ratios of isomannide and poly(ϵ-caprolactone) diol using a simple one-step polymerization without a catalyst. The polyurethane structures were confirmed by 1 H-nuclear magnetic resonance, Fourier transform infrared spectroscopy, and gel permeation chromatography. The glass transition temperatures were determined by thermal analysis to be between 25°C and 30°C. Degradation tests performed at 37°C in phosphate buffer produced mass losses of 5%–10% after 8 weeks. After 5 days of culture, using osteoblastic cells, the relative cell number on all the polyurethane films was only slightly lower than that of an optimized tissue culture plastic. These polymers offer significant promise with a simplistic synthesis and controlled degradation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Polymer composites and self-healing
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Nanobiomedical Science & WCU Research Center, Graduate School, Dankook University, Cheonan, South Korea
Department of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute, London, UK
References (27)
Show source-provided references
1. 10.1016/j.biomaterials.2004.02.00110.1016/j.biomaterials.2004.02.001 ↗
2. 10.1016/j.biomaterials.2010.07.01910.1016/j.biomaterials.2010.07.019 ↗
3. 10.1016/j.biomaterials.2006.01.03910.1016/j.biomaterials.2006.01.039 ↗
4. 10.1177/088391150935348510.1177/0883911509353485 ↗
5. 10.1177/088391151243830610.1177/0883911512438306 ↗
6. 10.1016/j.polymer.2005.12.00710.1016/j.polymer.2005.12.007 ↗
7. 10.1016/j.biomaterials.2004.11.00510.1016/j.biomaterials.2004.11.005 ↗
8. 10.1006/jsre.2000.604210.1006/jsre.2000.6042 ↗
9. 10.1016/j.molcatb.2011.02.01510.1016/j.molcatb.2011.02.015 ↗
10. 10.1177/088391150707336210.1177/0883911507073362 ↗
11. 10.1002/jbm.a.3070810.1002/jbm.a.30708 ↗
12. 10.1016/j.biomaterials.2007.08.03510.1016/j.biomaterials.2007.08.035 ↗
13. 10.1016/j.eurpolymj.2004.07.01510.1016/j.eurpolymj.2004.07.015 ↗
14. 10.1002/jbm.a.3209510.1002/jbm.a.32095 ↗
15. 10.1021/ma951386e10.1021/ma951386e ↗
16. 10.1007/BF0141239910.1007/BF01412399 ↗
17. 10.1177/088391150935881210.1177/0883911509358812 ↗
18. Lelah MD · 1986
19. 10.1002/jbm.1010010.1002/jbm.10100 ↗
20. 10.1002/jbm.a.3099210.1002/jbm.a.30992 ↗
21. Holzapfel GA · 2000
22. 10.1016/j.polymer.2004.11.02410.1016/j.polymer.2004.11.024 ↗
23. 10.1016/S0079-6700(02)00080-110.1016/S0079-6700(02)00080-1 ↗
24. 10.1002/jbm.82025030610.1002/jbm.820250306 ↗
25. 10.1177/088391151244053610.1177/0883911512440536 ↗
26. 10.1016/j.actbio.2009.01.03910.1016/j.actbio.2009.01.039 ↗
27. Koh T · BMC Complement Altern Med · 2012 · 78 · 1